Powered and Led by Women in Pharma

In an era marked by rapid technological advancements, this Women in Pharma panel convenes to explore the intersection of healthcare equity and digitalization, delving into the opportunities and challenges presented by digital technologies in shaping a more inclusive and accessible healthcare landscape for women and other marginalized groups. Throughout this session, we set out to foster a comprehensive dialogue among experts representing diverse fields, gaining insights into how digitalization can be harnessed to reduce healthcare disparities and ensure that advancements benefit all segments of society.

Throughout this panel we will discuss:

Equitable Access:

Exploring strategies to ensure that digital health tools and services are accessible to all, irrespective of socio-economic factors or geographic location.

Innovation and Inclusivity:

Examining how the private sector can contribute to the development of inclusive technologies that address the unique needs of diverse patient populations. Assessing the impact of public-private partnerships in fostering innovation while prioritizing healthcare equity.

Policy and Governance:

Analyzing the role of government policies in creating an enabling environment that promotes digital health without exacerbating existing disparities. Discussing regulatory frameworks that balance the need for innovation with safeguards against discrimination and unequal access.

Patient-Centric Perspectives:

Highlighting the patient experience in the digital age, with a focus on how digital tools can empower individuals while addressing issues of digital literacy and accessibility. Exploring the role of patient advocates in shaping policies that prioritize the needs of vulnerable and underserved communities.

Data for Impact:

Investigating the potential of health data collected through digital platforms in identifying and addressing health disparities. Emphasizing the importance of ethical data practices, patient privacy, and ensuring that data-driven interventions contribute to equitable healthcare outcomes.

Catherine Lunardi

CEO, GENAIZ

Appearances